CBUS Cibus, Inc.
Agricultural Chemicals · Nasdaq · SEC CIK 1705843 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY19.5%
TTM net income YoY18.8%
TTM EPS YoY46.1%
Revenue 3-yr CAGR81.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-1,326.7%
Net margin-2,131.4%
FCF margin-966.0%
EBITDA margin-1,243.0%
Returns
ROE-431.9%
ROA-30.6%
ROIC (approx.)-826.6%
Asset turnover0.01x
Leverage & solvency
Liabilities / assets101.9%
Debt / equity—
Current ratio0.95x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.45x
Accruals ratio-16.8%
Payout ratio—
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $800,000 | $994,000 | $1.68M | $1.06M | $615,000 | $933,000 | $1.03M | $1.21M |
| R&D expense | $7.91M | $8.51M | $8.72M | $9.39M | $10.78M | $12.23M | $11.80M | $12.43M |
| SG&A expense | $5.39M | $5.41M | $5.08M | $5.13M | $5.27M | $6.65M | $9.86M | $6.80M |
| Operating income | -$12.51M | -$12.93M | -$12.12M | -$22.57M | -$15.44M | -$17.95M | -$41.57M | -$18.02M |
| Pretax income | -$21.94M | -$22.14M | -$21.21M | -$31.94M | -$24.31M | -$26.53M | -$49.39M | -$25.80M |
| Income tax | $4,000 | $6,000 | $7,000 | $6,000 | -$6,000 | $27,000 | $2,000 | $6,000 |
| Net income | -$21.94M | -$22.14M | -$21.22M | -$31.29M | -$23.54M | -$25.37M | -$46.89M | -$23.10M |
| EBITDA | -$11.89M | -$12.24M | -$10.92M | -$21.28M | -$14.50M | -$16.85M | -$39.94M | -$16.38M |
| EPS (basic) | -0.29 | -0.29 | -0.33 | — | -0.44 | -0.61 | -1.34 | — |
| EPS (diluted) | -0.29 | -0.29 | -0.33 | — | -0.44 | -0.61 | -1.34 | — |
| Weighted avg. shares (diluted) | 76.89M | 76.76M | 65.20M | — | 52.93M | 41.62M | 35.05M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $10.71M | $20.43M | $30.32M | $9.92M | $23.89M | $36.46M | $23.59M | $14.43M |
| Receivables | $0 | $838,000 | $1.70M | $503,000 | $604,000 | $953,000 | $950,000 | $1.04M |
| Current assets | $13.25M | $23.46M | $33.07M | $12.07M | $26.24M | $39.84M | $25.88M | $16.95M |
| PP&E, net | $4.30M | $4.92M | $5.64M | $6.30M | $8.54M | $9.38M | $10.39M | $11.44M |
| Goodwill | $232.52M | $232.52M | $232.52M | $232.52M | $232.52M | $232.52M | $232.52M | $253.47M |
| Intangibles | $30.32M | $30.77M | $31.22M | $31.68M | $32.13M | $32.59M | $33.04M | $33.58M |
| Total assets | $301.48M | $313.45M | $324.20M | $305.05M | $330.23M | $346.20M | $335.05M | $350.07M |
| Current liabilities | $13.89M | $14.45M | $13.94M | $16.86M | $20.56M | $22.42M | $21.01M | $19.88M |
| Short-term debt | $547,000 | $812,000 | $194,000 | $435,000 | $662,000 | $966,000 | $334,000 | $436,000 |
| Long-term debt | $32,000 | $53,000 | $73,000 | $93,000 | $116,000 | $140,000 | $180,000 | $226,000 |
| Total debt | $579,000 | $865,000 | $267,000 | $528,000 | $778,000 | $1.11M | $514,000 | $662,000 |
| Total liabilities | $307.15M | $298.64M | $288.72M | $283.22M | $278.20M | $271.72M | $261.09M | $252.24M |
| Shareholders' equity | -$5.67M | $14.80M | $35.48M | $21.83M | $50.40M | $72.12M | $70.27M | $92.16M |
| Net debt | -$10.13M | -$19.56M | -$30.06M | -$9.39M | -$23.11M | -$35.36M | -$23.07M | -$13.77M |
| Shares outstanding | — | — | — | — | 54.26M | 54.19M | 34.37M | 29.66M |
| Cash flow statement | ||||||||
| Operating cash flow | -$9.30M | -$9.41M | -$11.49M | -$13.42M | -$11.74M | -$13.60M | -$11.83M | -$13.99M |
| Capital expenditure | $0 | -$42,000 | $115,000 | $86,000 | $108,000 | $93,000 | $291,000 | $56,000 |
| Free cash flow | -$9.30M | -$9.37M | -$11.60M | -$13.51M | -$11.85M | -$13.70M | -$12.12M | -$14.05M |
| Investing cash flow | $0 | $42,000 | -$72,000 | -$86,000 | -$108,000 | -$93,000 | -$291,000 | -$56,000 |
| Financing cash flow | -$413,000 | -$528,000 | $31.96M | -$458,000 | -$725,000 | $26.56M | $21.27M | -$306,000 |
| Depreciation & amortization | $620,000 | $681,000 | $1.20M | $1.29M | $939,000 | $1.09M | $1.63M | $1.65M |
| Stock-based compensation | $1.53M | $1.48M | $1.57M | $1.82M | $1.89M | $1.98M | $2.50M | $2.72M |
Free plan shows the latest 8 periods; Pro shows all 42 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.